Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 09/30 10:00:26 pm
118.13 USD   +0.73%
09/30 Celltrion doubtful on partnership with Pfizer
09/30 JOHNSON & JOHNS : Wall Street ends lower; Nasdaq Composite drops 1%
09/29 DOW MOVERS : Mrk, cat
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : J&J in $4 Billion Settlement Talks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/12/2013 | 11:16pm CEST

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to nymonitoring@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
09/30 Celltrion doubtful on partnership with Pfizer
09/30 JOHNSON & JOHNSON : Wall Street ends lower; Nasdaq Composite drops 1%
09/29 JOHNSON & JOHNSON : Announces Agreement to Acquire Abbott Medical Optics
09/29 JOHNSON & JOHNSON : Advances Commitment to Improve Global Health and Well-Being
09/29 JOHNSON & JOHNSON : New Erythema Data Have Been Reported by Investigators at Joh..
09/29 JOHNSON & JOHNSON : Recent Findings from Johnson & Johnson Has Provided New Info..
09/29 DOW MOVERS : Mrk, cat
09/28 GLOBAL DRUG ELUTING STENTS (DES) MAR : BOSTON SCIENTIFIC, JOHNSON and JOHNSON, A..
09/28 3D SIGNATURES : TSXV-listed 3D Signatures Names Jason Flowerday as New CEO
09/27 JOHNSON & JOHNSON : Two US companies eye Seagate land in Batu Kawan
More news
Sector news : Pharmaceuticals - NEC
09/30DJGLAXOSMITHKLINE : to Pay $20 Million to Settle SEC Bribery Probe
09/30 GlaxoSmithKline to pay $20 million to settle U.S. foreign bribery case
09/30DJGLAXOSMITHKLINE : to Pay $20 Million to Settle SEC Bribery Probe
09/30DJSHIRE : Files 8K - Other Events
09/30DJNovo Nordisk Announces Job Cuts
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09/30 Intra-Cellular Catatonic After Schizophrenia Fail
09/30 Medtronic's Artificial Pancreas Leads The Field
09/29 Buying Dividend Growth Stocks Without Looking; 17 Months Later.
09/29 PHILIP MORRIS INTERNATIONAL : Great Dividend Income Company With Inelastic Produ..
09/28 Obalon Therapeutics IPO May Inflate Company Prospects
Advertisement
Financials ($)
Sales 2016 72 075 M
EBIT 2016 21 925 M
Net income 2016 16 508 M
Finance 2016 14 428 M
Yield 2016 2,65%
P/E ratio 2016 20,12
P/E ratio 2017 17,72
EV / Sales 2016 4,28x
EV / Sales 2017 4,01x
Capitalization 323 189 M
More Financials
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 127 $
Spread / Average Target 7,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer
Susan L. Lindquist Independent Director
Charles O. Prince Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON15.00%323 189
ROCHE HOLDING LTD.-12.52%214 851
NOVARTIS AG-11.00%207 776
PFIZER INC.4.93%205 444
MERCK & CO., INC.18.16%172 577
GLAXOSMITHKLINE PLC19.67%103 947
More Results